Rapid	rapid	O	O	O	O
reversal	reversal	O	O	O	O
of	of	O	O	O	O
anticoagulation	anticoagulation	O	O	O	O
reduces	reduces	O	O	O	O
hemorrhage	hemorrhage	O	DISEASE	OTHERS	I
volume	volume	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
mouse	mouse	O	O	O	O
model	model	O	O	O	O
of	of	O	O	O	O
warfarin-associated	warfarin-associated	O	O	O	O
intracerebral	intracerebral	O	DISEASE	OTHERS	I
hemorrhage	hemorrhage	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Warfarin-associated	warfarin-associated	O	O	O	O
intracerebral	intracerebral	O	DISEASE	OTHERS	I
hemorrhage	hemorrhage	O	DISEASE	OTHERS	I
(	(	O	O	O	O
W-ICH	w-ich	O	O	O	O
)	)	O	O	O	O
is	is	O	O	O	O
a	a	O	O	O	O
severe	severe	O	O	O	O
type	type	O	O	O	O
of	of	O	O	O	O
stroke	stroke	O	DISEASE	OTHERS	I
.	.	O	O	O	O

There	there	O	O	O	O
is	is	O	O	O	O
no	no	O	O	O	O
consensus	consensus	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
optimal	optimal	O	O	O	O
treatment	treatment	O	O	O	O
for	for	O	O	O	O
W-ICH	w-ich	O	O	O	O
.	.	O	O	O	O

Using	using	O	O	O	O
a	a	O	O	O	O
mouse	mouse	O	O	O	O
model	model	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
tested	tested	O	O	O	O
whether	whether	O	O	O	O
the	the	O	O	O	O
rapid	rapid	O	O	O	O
reversal	reversal	O	O	O	O
of	of	O	O	O	O
anticoagulation	anticoagulation	O	O	O	O
using	using	O	O	O	O
human	human	O	O	O	O
prothrombin	prothrombin	O	O	OTHERS	I
complex	complex	O	O	OTHERS	I
concentrate	concentrate	O	O	OTHERS	I
(	(	O	O	O	O
PCC	pcc	O	O	OTHERS	I
)	)	O	O	O	O
can	can	O	O	O	O
reduce	reduce	O	O	O	O
hemorrhagic	hemorrhagic	O	DISEASE	OTHERS	I
blood	blood	O	O	O	O
volume	volume	O	O	O	O
.	.	O	O	O	O

Male	male	O	O	O	O
CD-1	cd-1	O	O	O	O
mice	mice	O	O	O	O
were	were	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
warfarin	warfarin	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
2	2	O	O	O	O
mg/kg	mg/kg	O	O	O	O
over	over	O	O	O	O
24	24	O	O	O	O
h	h	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
resulting	resulting	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
mean	mean	O	O	O	O
(	(	O	O	O	O
+	+	O	O	O	O
/-s.d	/-s.d	O	O	O	O
.	.	O	O	O	O
)	)	O	O	O	O
International	international	O	O	O	O
Normalized	normalized	O	O	O	O
Ratio	ratio	O	O	O	O
of	of	O	O	O	O
3.5+/-0.9	3.5+/-0.9	O	O	O	O
.	.	O	O	O	O

First	first	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
showed	showed	O	O	O	O
that	that	O	O	O	O
an	an	O	O	O	O
intravenous	intravenous	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
human	human	O	O	O	O
PCC	pcc	O	O	OTHERS	I
rapidly	rapidly	O	O	O	O
reversed	reversed	O	O	O	O
anticoagulation	anticoagulation	O	O	O	O
in	in	O	O	O	O
mice	mice	O	O	O	O
.	.	O	O	O	O

Second	second	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
stereotactic	stereotactic	O	O	O	O
injection	injection	O	O	O	O
of	of	O	O	O	O
collagenase	collagenase	O	O	O	O
was	was	O	O	O	O
administered	administered	O	O	O	O
to	to	O	O	O	O
induce	induce	O	O	O	O
hemorrhage	hemorrhage	O	DISEASE	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
right	right	O	O	O	O
striatum	striatum	O	O	O	O
.	.	O	O	O	O

Forty-five	forty-five	O	O	O	O
minutes	minutes	O	O	O	O
later	later	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
animals	animals	O	O	O	O
were	were	O	O	O	O
randomly	randomly	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
PCC	pcc	O	O	OTHERS	I
(	(	O	O	O	O
100	100	O	O	O	O
U/kg	u/kg	O	O	O	O
)	)	O	O	O	O
or	or	O	O	O	O
saline	saline	O	O	O	O
i.v	i.v	O	O	O	O
.	.	O	O	O	O
(	(	O	O	O	O
n=12	n=12	O	O	O	O
per	per	O	O	O	O
group	group	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Twenty-four	twenty-four	O	O	O	O
hours	hours	O	O	O	O
after	after	O	O	O	O
hemorrhage	hemorrhage	O	DISEASE	OTHERS	I
induction	induction	O	O	O	O
,	,	O	O	O	O
hemorrhagic	hemorrhagic	O	DISEASE	OTHERS	I
blood	blood	O	O	O	O
volume	volume	O	O	O	O
was	was	O	O	O	O
quantified	quantified	O	O	O	O
using	using	O	O	O	O
a	a	O	O	O	O
photometric	photometric	O	O	O	O
hemoglobin	hemoglobin	O	O	O	O
assay	assay	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
mean	mean	O	O	O	O
hemorrhagic	hemorrhagic	O	DISEASE	OTHERS	I
blood	blood	O	O	O	O
volume	volume	O	O	O	O
was	was	O	O	O	O
reduced	reduced	O	O	O	O
in	in	O	O	O	O
PCC-treated	pcc-treated	O	O	O	O
animals	animals	O	O	O	O
(	(	O	O	O	O
6.5+/-3.1	6.5+/-3.1	O	O	O	O
microL	microl	O	O	O	O
)	)	O	O	O	O
compared	compared	O	O	O	O
with	with	O	O	O	O
saline	saline	O	O	O	O
controls	controls	O	O	O	O
(	(	O	O	O	O
15.3+/-11.2	15.3+/-11.2	O	O	O	O
microL	microl	O	O	O	O
,	,	O	O	O	O
P=0.015	p=0.015	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
the	the	O	O	O	O
saline	saline	O	O	O	O
group	group	O	O	O	O
,	,	O	O	O	O
45	45	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
mice	mice	O	O	O	O
developed	developed	O	O	O	O
large	large	O	O	O	O
hematomas	hematomas	O	O	OTHERS	I
(	(	O	O	O	O
i.e.	i.e.	O	O	O	O
,	,	O	O	O	O
>	>	O	O	O	O
15	15	O	O	O	O
microL	microl	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
contrast	contrast	O	O	OTHERS	I
,	,	O	O	O	O
such	such	O	O	O	O
extensive	extensive	O	O	O	O
lesions	lesions	O	O	O	O
were	were	O	O	O	O
never	never	O	O	O	O
found	found	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
PCC	pcc	O	O	OTHERS	I
group	group	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
provide	provide	O	O	O	O
experimental	experimental	O	O	O	O
data	data	O	O	O	O
suggesting	suggesting	O	O	O	O
PCC	pcc	O	O	OTHERS	I
to	to	O	O	O	O
be	be	O	O	O	O
an	an	O	O	O	O
effective	effective	O	O	O	O
acute	acute	O	O	O	O
treatment	treatment	O	O	O	O
for	for	O	O	O	O
W-ICH	w-ich	O	O	O	O
in	in	O	O	O	O
terms	terms	O	O	O	O
of	of	O	O	O	O
reducing	reducing	O	O	O	O
hemorrhagic	hemorrhagic	O	DISEASE	OTHERS	I
blood	blood	O	O	O	O
volume	volume	O	O	O	O
.	.	O	O	O	O

Future	future	O	O	O	O
studies	studies	O	O	O	O
are	are	O	O	O	O
needed	needed	O	O	O	O
to	to	O	O	O	O
assess	assess	O	O	O	O
the	the	O	O	O	O
therapeutic	therapeutic	O	O	O	O
potential	potential	O	O	O	O
emerging	emerging	O	O	O	O
from	from	O	O	O	O
our	our	O	O	O	O
finding	finding	O	O	O	O
for	for	O	O	O	O
human	human	O	O	O	O
W-ICH	w-ich	O	O	O	O
.	.	O	O	O	O

